ENOVEnovis Corporation
$17.71-45% 1Y
$17.71
$17.4452 weeks$32.87
The financials
Enovis Corporation by the numbers
Enovis Corporation (ENOV) reported revenue of $583M in Q2 2026 (quarter ended Jul 3, 2026), up 3.2% from the same quarter a year earlier. That came with a gross margin of 62% and net loss of $1.2M. For the full year FY2025, revenue was $2.25B (+6.7% year on year) and net income −$1.18B. Its largest product in Q2 2026 was Surgical at $138M, 32% of the disclosed total, just ahead of Bracing And Support at 30%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $583M | $565M | +3.2% |
| Gross profit | $359M | $335M | +7.3% |
| Operating income | $17M | −$17M | to a profit |
| Net income | −$1.2M | −$37M | n/a |
| Diluted EPS | −$0.02 | −$0.64 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Surgical | $138M | 32% |
| Bracing And Support | $128M | 30% |
| Prevention And Recovery | $101M | 24% |
| Other Prevention And Recovery | $60M | 14% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $426.1M (+1.2%)
Surgical grew +6.4% year on yearOther Prevention And Recovery -16% year on year
Segment Latestquarter on quarteryear on year
- Surgical$137.8M$137.8Mquarter on quarter -7.6%year on year +6.4%-7.6%+6.4%
- Bracing And Support$127.6M$127.6Mquarter on quarter +11%year on year +5.6%+11%+5.6%
- Prevention And Recovery$101.0M$101.0Mquarter on quarter -0.27%year on year +2.1%-0.27%+2.1%
- Other Prevention And Recovery$59.6M$59.6Mquarter on quarter +6.8%year on year -16%+6.8%-16%